118 related articles for article (PubMed ID: 6768335)
21. [Leser-Trélat sign associated with Sézary syndrome and transitional cell carcinoma of the bladder].
Martínez-Morán C; Sanz-Muñoz C; Miranda-Romero A
Actas Dermosifiliogr; 2007 Apr; 98(3):214-5. PubMed ID: 17504710
[No Abstract] [Full Text] [Related]
22. Il-31 does not correlate to pruritus related to early stage cutaneous T-cell lymphomas but is involved in pathogenesis of the disease.
Malek M; Gleń J; Rębała K; Kowalczyk A; Sobjanek M; Nowicki R; Ruckemann-Dziurdzińska K; Sokołowska-Wojdyło M
Acta Derm Venereol; 2015 Mar; 95(3):283-8. PubMed ID: 25176053
[TBL] [Abstract][Full Text] [Related]
23. Antibody-dependent cellular cytotoxicity in patients with mycosis fungoides and Sézary syndrome.
Asbell SO; Gadol N; Saluk P; Vonderheid EC; Brady LW
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):609-13. PubMed ID: 101489
[No Abstract] [Full Text] [Related]
24. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
25. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
[TBL] [Abstract][Full Text] [Related]
26. Sézary's syndrome: a case report including ultrastructural and immunohistochemical characterization of the cellular infiltrates.
Katoh M; Kizukuri K; Jimbow K
J Dermatol; 1981 Feb; 8(1):53-61. PubMed ID: 7014682
[No Abstract] [Full Text] [Related]
27. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
28. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome.
Meissner K; Löning T; Rehpenning W
In Vivo; 1993; 7(3):277-80. PubMed ID: 8357970
[TBL] [Abstract][Full Text] [Related]
29. [Humoral immunity indices in mycosis fungoides with a secondary infection during the immunodepressive therapy period].
Krepker IaB; Iurina TM
Vestn Dermatol Venerol; 1980 Jun; (6):19-23. PubMed ID: 7395361
[No Abstract] [Full Text] [Related]
30. Monoclonal gammopathies in Sézary syndrome: a report of four new cases and a review of the literature.
Kövary PM; Suter L; Macher E; Niedorf H; Grundmann E; Lukitsch O; Herzberg J; Intorp H; Schürmeyer E; Kamanabroo D; Losse H
Cancer; 1981 Aug; 48(3):788-92. PubMed ID: 7248906
[TBL] [Abstract][Full Text] [Related]
31. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
[TBL] [Abstract][Full Text] [Related]
32. [Item no 164: malignant lymphoma: cutaneous lymphoma].
CEDEF
Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
[No Abstract] [Full Text] [Related]
33. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
[TBL] [Abstract][Full Text] [Related]
34. Evolution of Sézary syndrome in the course of hairy cell leukemia.
Zucker-Franklin D; Amorosi EL; Ritz ND
Blood; 1982 Jun; 59(6):1181-90. PubMed ID: 7082821
[TBL] [Abstract][Full Text] [Related]
35. Atopic dermatitis and Sézary syndrome.
Rajka G; Winkelmann RK
Arch Dermatol; 1984 Jan; 120(1):83-4. PubMed ID: 6691719
[TBL] [Abstract][Full Text] [Related]
36. [Membrane markers in chronic lymphoproliferative diseases].
Matutes E; San Miguel JF; Catovsky D
Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
[No Abstract] [Full Text] [Related]
37. [Sezary syndrome with serum monoclonal immunoglobulin. Absence of detectable shared idiotype between the monoclonal immunoglobulin and membrane structures of the Sezary cells (author's transl)].
Preud'homme JL; Sohier J; Danon F
Nouv Presse Med; 1980 Mar; 9(17):1215-7. PubMed ID: 7005868
[TBL] [Abstract][Full Text] [Related]
38. Issue Highlights - May 2019.
Orfao A
Cytometry B Clin Cytom; 2019 May; 96(3):177-180. PubMed ID: 31091004
[No Abstract] [Full Text] [Related]
39. Basaloid folliculolymphoid hyperplasia: a distinctive finding in follicular mycosis fungoides.
Gerami P; Guitart J
J Cutan Pathol; 2007 Dec; 34 Suppl 1():29-32. PubMed ID: 17997735
[TBL] [Abstract][Full Text] [Related]
40. Journal Club: Mycosis fungoides and Sézary syndrome: an update on a classic disease.
González DV; Rosell-Díaz ÁM; Chircop I; Lé AM; Dege T; Byrne N; Reynaud V; García-Piqueras P
Eur J Dermatol; 2023 Dec; 33(6):714-718. PubMed ID: 38465567
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
